This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
acute respiratory | 176 |
coronavirus disease | 173 |
novel coronavirus | 169 |
respiratory syndrome | 134 |
severe acute | 114 |
risk factors | 109 |
systematic review | 96 |
spike protein | 92 |
syndrome coronavirus | 88 |
older adults | 86 |
present study | 86 |
intensive care | 80 |
perceived stress | 73 |
clinical characteristics | 72 |
severe covid | 71 |
spinal cord | 71 |
converting enzyme | 66 |
brain injury | 64 |
respiratory distress | 60 |
health care | 58 |
clin med | 58 |
jcm sha | 58 |
doc id | 58 |
med doi | 58 |
cord uid | 58 |
traumatic brain | 57 |
incubation period | 57 |
stim group | 53 |
induced asthma | 53 |
major epidemic | 53 |
immune response | 49 |
heart failure | 49 |
critically ill | 49 |
mesenchymal stem | 48 |
cohort study | 48 |
asthma exacerbations | 48 |
distress syndrome | 47 |
viral infection | 47 |
hospitalized patients | 47 |
epithelial cells | 46 |
clinical features | 46 |
hospital admission | 46 |
prehospital intubation | 46 |
world health | 45 |
kidney transplant | 45 |
authors declare | 45 |
higher risk | 44 |
increased risk | 44 |
pulmonary disease | 43 |
clinical course | 42 |
statistically significant | 42 |
care unit | 42 |
clinical practice | 42 |
public health | 42 |
mechanical ventilation | 41 |
microbiota transplantation | 41 |
health organization | 40 |
chronic obstructive | 40 |
obstructive pulmonary | 40 |
qt interval | 39 |
disease severity | 39 |
cardiovascular disease | 39 |
inflammatory syndrome | 38 |
angiotensin ii | 38 |
employment status | 38 |
general population | 38 |
blood pressure | 38 |
transplant recipients | 38 |
diabetes mellitus | 37 |
stem cells | 37 |
immune system | 37 |
vr exercise | 37 |
inflammatory cytokines | 37 |
prolonged qtc | 37 |
mental health | 36 |
lopinavir ritonavir | 36 |
cardiac rehabilitation | 36 |
performed using | 36 |
two groups | 36 |
multisystem inflammatory | 36 |
ill patients | 36 |
available online | 36 |
significantly higher | 35 |
rbd domain | 35 |
cytokine storm | 35 |
igm iga | 35 |
significant differences | 35 |
lung injury | 35 |
control group | 35 |
among patients | 35 |
logistic regression | 34 |
several studies | 34 |
cord injury | 34 |
viral rna | 34 |
united states | 33 |
inflammatory response | 33 |
case series | 33 |
confirmed cases | 33 |
spike glycoprotein | 33 |
open access | 33 |
continuous variables | 33 |
creative commons | 32 |
access article | 32 |
commons attribution | 32 |
patients infected | 32 |
observational study | 32 |
respiratory failure | 32 |
article distributed | 32 |
weight loss | 31 |
previous studies | 31 |
copd patients | 31 |
risk factor | 31 |
job satisfaction | 31 |
emergency department | 31 |
icu transfer | 31 |
data collection | 30 |
derived evs | 30 |
airway inflammation | 30 |
fecal microbiota | 30 |
gut microbiota | 30 |
infected patients | 30 |
global score | 30 |
exported cases | 30 |
randomized controlled | 30 |
middle east | 30 |
physical activity | 30 |
sample size | 30 |
exercise capacity | 30 |
significantly associated | 30 |
sestamibi uptake | 29 |
informed consent | 29 |
illness onset | 29 |
viral infections | 29 |
outside china | 29 |
east respiratory | 29 |
one year | 28 |
study population | 28 |
travel volume | 28 |
sexual activity | 28 |
robotic colonoscope | 27 |
human transmission | 27 |
controlled trial | 27 |
categorical variables | 27 |
patients without | 27 |
virtual reality | 26 |
endothelial cells | 26 |
ace receptor | 26 |
factors associated | 26 |
myocardial infarction | 26 |
reactive protein | 26 |
like lesions | 25 |
new york | 25 |
qtc interval | 25 |
recent study | 25 |
ischemic stroke | 25 |
mouse model | 25 |
higher levels | 25 |
skin lesions | 25 |
least one | 25 |
ng ml | 24 |
aceis arbs | 24 |
social distancing | 24 |
cardiovascular diseases | 24 |
normal range | 24 |
receptor blockers | 24 |
growth factor | 24 |
lower limb | 24 |
pregnancy complications | 24 |
clinical data | 24 |
clinical trial | 24 |
supplementary materials | 24 |
respiratory tract | 24 |
patients admitted | 23 |
mean age | 23 |
baseline characteristics | 23 |
ongoing outbreak | 23 |
kidney disease | 23 |
machine learning | 23 |
mtc sestamibi | 23 |
clostridium difficile | 23 |
ktx recipients | 23 |
preventive measures | 23 |
year post | 22 |
trimer cavity | 22 |
artificial intelligence | 22 |
clinical trials | 22 |
respiratory disease | 22 |
parathyroid carcinoma | 22 |
robotic colonoscopes | 22 |
patients treated | 22 |
family members | 22 |
difficile infection | 22 |
heart disease | 22 |
arterial hypertension | 21 |
older age | 21 |
time delay | 21 |
clinical outcomes | 21 |
cause mortality | 21 |
coronavirus infection | 21 |
nasopharyngeal swab | 21 |
mortality rate | 21 |
rehabilitation program | 21 |
high risk | 21 |
cord stimulation | 21 |
myocardial injury | 20 |
health outcomes | 20 |
infectious disease | 20 |
disease progression | 20 |
transplant recipient | 20 |
retrospective cohort | 20 |
median time | 20 |
os max | 19 |
basic reproduction | 19 |
systematic reviews | 19 |
regression analysis | 19 |
high levels | 19 |
stem cell | 19 |
igg index | 19 |
virus infection | 19 |
pregnant women | 19 |
patients hospitalized | 19 |
pilot study | 19 |
acute lung | 19 |
psychological distress | 19 |
vascular invasion | 19 |
also reported | 19 |
confidence interval | 19 |
reproduction number | 19 |
study protocol | 19 |
wet market | 19 |
molecular mimicry | 19 |
mitochondrial dysfunction | 19 |
significant difference | 19 |
chi square | 18 |
taste bud | 18 |
exponential growth | 18 |
immune cells | 18 |
derived exosomes | 18 |
stand training | 18 |
emotional stability | 18 |
antibody titers | 18 |
oxidative stress | 18 |
pulmonary rehabilitation | 18 |
statistical significance | 18 |
related quality | 18 |
police employees | 18 |
host cell | 18 |
icu admission | 18 |
severe cases | 18 |
retrospective study | 18 |
cr program | 18 |
severe disease | 18 |
asthma exacerbation | 17 |
study design | 17 |
faecal microbiota | 17 |
coping strategies | 17 |
chain reaction | 17 |
medical care | 17 |
human coronavirus | 17 |
bone marrow | 17 |
temporally associated | 17 |
italian population | 17 |
older patients | 17 |
square test | 17 |
infected pneumonia | 17 |
cardiac injury | 17 |
future studies | 17 |
exclusion criteria | 17 |
inclusion criteria | 17 |
market exposure | 17 |
time points | 17 |
elderly patients | 17 |
standard deviation | 17 |
polymerase chain | 17 |
epidemic peak | 17 |
viral load | 17 |
years old | 17 |
biliary stenting | 17 |
viral shedding | 16 |
wuhan residents | 16 |
fatality rate | 16 |
may also | 16 |
aldosterone system | 16 |
ethics committee | 16 |
smoking history | 16 |
several women | 16 |
may lead | 16 |
swab specimens | 16 |
health system | 16 |
clinical management | 16 |
cxr global | 16 |
lymphocyte count | 16 |
psychiatric problems | 16 |
obese class | 16 |
patients diagnosed | 16 |
sars coronavirus | 16 |
outcome measures | 16 |
another study | 16 |
biliary stents | 16 |
confirmed covid | 16 |
atypical pneumonia | 16 |
significantly lower | 16 |
ace expression | 15 |
angiotensin converting | 15 |
new coronavirus | 15 |
university hospital | 15 |
regression model | 15 |
disseminated intravascular | 15 |
colorectal cancer | 15 |
salivary swab | 15 |
multisystem syndrome | 15 |
candidate pathogen | 15 |
crp levels | 15 |
infectious diseases | 15 |
statistical analysis | 15 |
pregnancy loss | 15 |
solid organ | 15 |
transmission dynamics | 15 |
term care | 15 |
vital signs | 15 |
motor complete | 15 |
bat sars | 15 |
movement disorder | 15 |
coronary artery | 15 |
computed tomography | 15 |
sestamibi spect | 15 |
inflammatory multisystem | 15 |
odds ratio | 15 |
exercise training | 15 |
psychological impact | 15 |
obese subjects | 15 |
amino acid | 15 |
two weeks | 15 |
aldosterone levels | 15 |
syndrome temporally | 15 |
lower rpcp | 15 |
systemic inflammation | 15 |
motor ability | 15 |
clinical studies | 15 |
multivariate analysis | 15 |
sexual partner | 15 |
analyzed using | 15 |
disease control | 15 |
south korea | 14 |
adipose tissue | 14 |
wii fit | 14 |
peer review | 14 |
organ transplant | 14 |
dimer levels | 14 |
adverse events | 14 |
sectional study | 14 |
angiotensin receptor | 14 |
significant increase | 14 |
healthcare workers | 14 |
type diabetes | 14 |
iga index | 14 |
tissue damage | 14 |
metabolic syndrome | 14 |
median age | 14 |
cell receptor | 14 |
progression group | 14 |
receptor binding | 14 |
higher prevalence | 14 |
intravascular coagulation | 14 |
data analysis | 14 |
injury severity | 14 |
improvement stabilization | 14 |
case fatality | 14 |
palliative care | 14 |
study conducted | 14 |
considered statistically | 14 |
inflammatory mediators | 14 |
laboratory tests | 14 |
severe traumatic | 14 |
respiratory symptoms | 14 |
minority communities | 14 |
important role | 14 |
determine whether | 14 |
one participant | 13 |
respiratory diseases | 13 |
european society | 13 |
airway epithelial | 13 |
severe clinical | 13 |
koch institute | 13 |
related factors | 13 |
binding domain | 13 |
general health | 13 |
dendritic cells | 13 |
recurrent pregnancy | 13 |
corona virus | 13 |
emergency departments | 13 |
supplementary table | 13 |
robert koch | 13 |
body mass | 13 |
one patient | 13 |
syncytial virus | 13 |
license key | 13 |
research received | 13 |
mildly symptomatic | 13 |
two patients | 13 |
control women | 13 |
respiratory syncytial | 13 |
infected cases | 13 |
motor control | 13 |
chronic respiratory | 13 |
invasive mechanical | 13 |
office visits | 13 |
ulcerative colitis | 13 |
mass index | 13 |
heart rate | 13 |
coronavirus pneumonia | 13 |
literature review | 13 |
also found | 12 |
respiratory rate | 12 |
stabilization group | 12 |
positive anti | 12 |
linear regression | 12 |
fatal course | 12 |
patients reported | 12 |
healthy lifestyle | 12 |
chronic heart | 12 |
weight management | 12 |
nitric oxide | 12 |
body weight | 12 |
european countries | 12 |
ebola virus | 12 |
european association | 12 |
cardiac disease | 12 |
may contribute | 12 |
outcomes among | 12 |
current study | 12 |
coronavirus outbreak | 12 |
case reports | 12 |
primary outcome | 12 |
kawasaki disease | 12 |
based cardiac | 12 |
sars cov | 12 |
th centile | 12 |
based cr | 12 |
secondary prevention | 12 |
better understanding | 12 |
md simulations | 12 |
minority populations | 12 |
epidemic curve | 12 |
chronic kidney | 12 |
class iii | 12 |
clinical status | 12 |
rna viruses | 12 |
high level | 12 |
gas exchange | 12 |
time series | 12 |
patients affected | 12 |
physical exercise | 12 |
previous research | 12 |
table shows | 12 |
higher compared | 12 |
first case | 12 |
paediatric inflammatory | 12 |
olfactory epithelium | 12 |
one study | 12 |
platelet counts | 12 |
kcdc classification | 12 |
social dysfunction | 12 |
coronavirus infections | 12 |
cov infection | 12 |
avoidance coping | 12 |
chronic diseases | 12 |
adult inpatients | 12 |
hospitalized covid | 12 |
novel pathogen | 12 |
hypertensive patients | 12 |
acute myocardial | 12 |
laboratory testing | 11 |
york city | 11 |
small sample | 11 |
hamming distance | 11 |
predictive value | 11 |
high perceived | 11 |
consecutive patients | 11 |
prolonged qt | 11 |
transfer within | 11 |
behavioural skills | 11 |
organ dysfunction | 11 |
positively correlated | 11 |
analysis revealed | 11 |
independently associated | 11 |
brain tissue | 11 |
emergency room | 11 |
former smokers | 11 |
national institute | 11 |
endothelial cell | 11 |
previous losses | 11 |
severe course | 11 |
pneumonia outbreak | 11 |
magnetic field | 11 |
available information | 11 |
cecal intubation | 11 |
optical coherence | 11 |
exercise interventions | 11 |
employment rates | 11 |
critical care | 11 |
orf ab | 11 |
global pandemic | 11 |
symptomatic patients | 11 |
higher mortality | 11 |
disease course | 11 |
previous reports | 11 |
candidate pathogens | 11 |
white blood | 11 |
euclidean distance | 11 |
protective effect | 11 |
lung ultrasound | 11 |
cardiac function | 11 |
systemic arterial | 11 |
medical records | 11 |
serological tests | 11 |
injury patterns | 11 |
prospective cohort | 11 |
recurrent cdi | 11 |
interquartile range | 11 |
prothrombin time | 11 |
nucleocapsid protein | 11 |
type i | 11 |
real time | 11 |
induced lung | 11 |
medical center | 11 |
wuhan city | 11 |
global health | 11 |
humoral immune | 11 |
immersive vr | 11 |
igg antibodies | 11 |
ali ards | 11 |
patient management | 11 |
among older | 11 |
biliary stent | 11 |
univariate analysis | 11 |
minimally invasive | 11 |
ct values | 11 |
current outbreak | 11 |
prehospital setting | 11 |
clinical symptoms | 11 |
secondary cases | 11 |
high rate | 11 |
many studies | 11 |
icu stay | 11 |
pg ml | 11 |
ml kg | 11 |
blood cell | 11 |
sexual intercourse | 11 |
early stages | 11 |
prognostic factors | 11 |
upper respiratory | 10 |
viral antigens | 10 |
enzyme inhibitors | 10 |
socioeconomic status | 10 |
cardiac involvement | 10 |
therapeutic interventions | 10 |
platelet count | 10 |
motor scores | 10 |
publicly available | 10 |
aged years | 10 |
study reported | 10 |
care facilities | 10 |
walk test | 10 |
lus global | 10 |
related complications | 10 |
healthcare services | 10 |
fire brigade | 10 |
unknown etiology | 10 |
large number | 10 |
previous study | 10 |
stent related | 10 |
premorbid psychiatric | 10 |
studies showed | 10 |
promising results | 10 |
neutralizing antibodies | 10 |
feature vectors | 10 |
even though | 10 |
motor symptoms | 10 |
diagnosed outside | 10 |
seafood market | 10 |
severe form | 10 |
infected person | 10 |
dependent variable | 10 |
volume reduction | 10 |
time point | 10 |
reported cases | 10 |
available data | 10 |
bile duct | 10 |
seven days | 10 |
study period | 10 |
task force | 10 |
detection rate | 10 |
th percentile | 10 |
early stage | 10 |
ii receptor | 10 |
among minority | 10 |
scientific community | 10 |
severe coronavirus | 10 |
remote monitoring | 10 |
advanced age | 10 |
ivig alone | 10 |
care workers | 10 |
atrial fibrillation | 10 |
test set | 10 |
inflammatory bowel | 10 |
bud cells | 10 |
health disparities | 10 |
ill covid | 10 |
cardiovascular risk | 10 |
health authorities | 10 |
blood flow | 10 |
cellular senescence | 10 |
respiratory support | 10 |
renal failure | 10 |
clinical deterioration | 10 |
paris fire | 10 |
intestinal microbiota | 10 |
transmission risk | 10 |
controlled trials | 10 |
lower levels | 10 |
coherence tomography | 10 |
capsule endoscope | 10 |
statistical computing | 10 |
ace receptors | 10 |
many women | 10 |
septic shock | 10 |
extracellular vesicles | 10 |
statistical analyses | 10 |
cancer screening | 10 |
digital health | 10 |
patients showed | 10 |
rna polymerase | 10 |
antithrombin activity | 10 |
healthcare professionals | 10 |
exercise program | 10 |
external funding | 10 |
influenza virus | 10 |
epidemic size | 10 |
overall complications | 10 |
may result | 10 |
epidemiological characteristics | 10 |
first step | 10 |
case report | 10 |
right truncation | 10 |
see table | 10 |
virtual screening | 10 |
type ii | 10 |
human coronaviruses | 10 |
longitudinal study | 10 |
health professionals | 10 |
proliferation index | 10 |
serum levels | 10 |
chest ct | 10 |
functional capacity | 10 |
focused coping | 10 |
natriuretic peptide | 9 |
virus disease | 9 |
may increase | 9 |
medical staff | 9 |
one comorbidity | 9 |
written informed | 9 |
tomography angiography | 9 |
respiratory infection | 9 |
two different | 9 |
normal distribution | 9 |
exact test | 9 |
study clinical | 9 |
livedo reticularis | 9 |
published version | 9 |
acute phase | 9 |
hrv infection | 9 |
derived mvs | 9 |
mortality rates | 9 |
observational studies | 9 |
parathyroid adenoma | 9 |
selection bias | 9 |
limited access | 9 |
closely related | 9 |
acquired brain | 9 |
interval prolongation | 9 |
reactive oxygen | 9 |
tested positive | 9 |
cholangitis complicating | 9 |
diagnostic criteria | 9 |
vascular leakage | 9 |
class imbalance | 9 |
transcutaneous spinal | 9 |
acute kidney | 9 |
primary endpoint | 9 |
author contributions | 9 |
care units | 9 |
sirt activator | 9 |
physical health | 9 |
baseline qtc | 9 |
muscle activity | 9 |
tca cycle | 9 |
treatment options | 9 |
secondary rpl | 9 |
recent years | 9 |
cumulative number | 9 |
environmental factors | 9 |
induced inflammation | 9 |
ischemic heart | 9 |
less severe | 9 |
results suggest | 9 |
kidney transplantation | 9 |
pediatric patients | 9 |
lifestyle changes | 9 |
missing data | 9 |
mitochondrial dna | 9 |
disease patients | 9 |
clinical manifestations | 9 |
lower limbs | 9 |
endotics system | 9 |
infected individuals | 9 |
adult patients | 9 |
gold standard | 9 |
one sub | 9 |
final model | 9 |
close contact | 9 |
multiple organ | 9 |
time period | 9 |
still unclear | 9 |
social determinants | 9 |
healthy food | 9 |
bowel disease | 9 |
data collected | 9 |
possible association | 9 |
cardiovascular system | 9 |
patients stated | 9 |
three different | 9 |
oxygen species | 9 |
porcine colon | 9 |
confidence intervals | 9 |
funnel plot | 9 |
working channel | 9 |
respiratory viruses | 9 |
chronic disease | 9 |
coma scale | 9 |
molecular mechanisms | 9 |
complicating choledocholithiasis | 9 |
current situation | 9 |
cognitive functioning | 9 |
may play | 9 |
vivo tests | 9 |
potential risk | 9 |
capsule endoscopy | 9 |
system inhibitors | 9 |
recent meta | 9 |
patient groups | 9 |
might also | 9 |
recent studies | 9 |
test results | 9 |
huanan seafood | 9 |
expected number | 9 |
causative agent | 9 |
original magnification | 9 |
old man | 9 |
study showed | 9 |
lung diseases | 9 |
emg activity | 9 |
therapeutic target | 9 |
daily life | 9 |
patients requiring | 9 |
nervous system | 9 |
unreported cases | 9 |
among others | 9 |
pcr results | 9 |
hospital treatment | 9 |
prognostic value | 9 |
trait anxiety | 9 |
per week | 9 |
molecular dynamics | 9 |
gastrointestinal tract | 9 |
treatment strategies | 9 |
health status | 9 |
neutrophilic airway | 9 |
cell entry | 9 |
included studies | 9 |
disease clinical | 9 |
vascular endothelial | 9 |
long term | 9 |
additional information | 9 |
psychopathological symptomatology | 9 |
oxygen saturation | 9 |
reduced travel | 9 |
group compared | 9 |
studies included | 9 |
acei arb | 9 |
among emergency | 9 |
social support | 9 |
biliary colic | 9 |
cell death | 9 |
severely ill | 8 |
corticosteroid therapy | 8 |
two participants | 8 |
behaviour change | 8 |
diabetic patients | 8 |
left ventricular | 8 |
clinical conditions | 8 |
satisfaction among | 8 |
host cells | 8 |
induced acute | 8 |
induced coagulopathy | 8 |
may impact | 8 |
pcr tests | 8 |
disease prevention | 8 |
high prevalence | 8 |
coping styles | 8 |
different time | 8 |
least two | 8 |
arb group | 8 |
three times | 8 |
internal locus | 8 |
healthy subjects | 8 |
beneficial effects | 8 |
mortality among | 8 |
inflammatory cells | 8 |
retrospective analysis | 8 |
kidney injury | 8 |
beneficial effect | 8 |
marital status | 8 |
organ failure | 8 |
adjusted normal | 8 |
glasgow coma | 8 |
among covid | 8 |
significant decrease | 8 |
robotic colonoscopy | 8 |
gestational diabetes | 8 |
human bone | 8 |
psychological outcomes | 8 |
th cells | 8 |
health systems | 8 |
lower respiratory | 8 |
maternal obesity | 8 |
cell count | 8 |
human respiratory | 8 |
recurrent clostridium | 8 |
prolonged prothrombin | 8 |
severe respiratory | 8 |
infection rate | 8 |
individual patient | 8 |
wide range | 8 |
pneumocytes type | 8 |
intervention strategies | 8 |
gastrointestinal symptoms | 8 |
well established | 8 |
cerebral artery | 8 |
pd networks | 8 |
laboratory parameters | 8 |
previously reported | 8 |
care system | 8 |
nine patients | 8 |
different levels | 8 |
point likert | 8 |
assisted colonoscopy | 8 |
transplanted patients | 8 |
lose weight | 8 |
adverse outcomes | 8 |
donor selection | 8 |
complications rate | 8 |
effective treatment | 8 |
stromal cells | 8 |
descriptive statistics | 8 |
lung disease | 8 |
mild symptoms | 8 |
health risks | 8 |
protein levels | 8 |
propensity score | 8 |
patients presented | 8 |
regression analyses | 8 |
mild cases | 8 |
room air | 8 |
studies reported | 8 |
tumor necrosis | 8 |
necrosis factor | 8 |
week follow | 8 |
term biliary | 8 |
receiver operating | 8 |
monomer form | 8 |
ordinal scale | 8 |
stent insertion | 8 |
sociodemographic variables | 8 |
big five | 8 |
cerebrovascular disease | 8 |
current status | 8 |
personality traits | 8 |
comorbidity index | 8 |
innate immunity | 8 |
pneumonia cases | 8 |
year follow | 8 |
differential diagnosis | 8 |
previous treatment | 8 |
relatively low | 8 |
virus transmission | 8 |
psychological traits | 8 |
tbi severity | 8 |
infection rates | 8 |
limitations due | 8 |
antibody responses | 8 |
comparative analysis | 8 |
also shown | 8 |
nursing staff | 8 |
inflammatory markers | 8 |
five mwts | 8 |
therapeutic strategy | 8 |
cell proliferation | 8 |
wuhan clinical | 8 |
viral proteins | 8 |
adenoma detection | 8 |
renal function | 8 |
renal transplant | 8 |
blood glucose | 8 |
demographic characteristics | 8 |
nucleic acid | 8 |
medical history | 8 |
robotic capsule | 8 |
parathyroid lesions | 8 |
confounding factors | 8 |
charlson comorbidity | 8 |
low perceived | 8 |
endothelial dysfunction | 8 |
neuromuscular disorder | 8 |
protease inhibitor | 8 |
transmission events | 8 |
peripheral arterial | 8 |
several limitations | 8 |
clinical signs | 8 |
findings suggest | 8 |
angiotensin system | 8 |
existing comorbidities | 8 |
optimal donor | 8 |
average thickness | 8 |
icu patients | 8 |
umbilical cord | 8 |
well informed | 8 |
recently reported | 8 |
higher rates | 8 |
arterial disease | 8 |
patients also | 8 |
imb model | 8 |
airway remodeling | 8 |
animal models | 8 |
less likely | 8 |
hubei province | 8 |
alveolar macrophages | 8 |
time intervals | 8 |
permanent magnet | 8 |
vast majority | 8 |
role limitations | 8 |
respiratory illness | 7 |
first half | 7 |
mitochondrial transfer | 7 |
first seven | 7 |
commercially available | 7 |
complete spinal | 7 |
million people | 7 |
future research | 7 |
retrospective observational | 7 |
chinese population | 7 |
serious injuries | 7 |
ace protein | 7 |
suspected covid | 7 |
hypoxemia index | 7 |
term outcomes | 7 |
plasma membrane | 7 |
many patients | 7 |
review board | 7 |
human proteins | 7 |
systolic blood | 7 |
human cells | 7 |
traditional exercise | 7 |
mg dl | 7 |
social media | 7 |
italian version | 7 |
hospital discharge | 7 |
coronavirus covid | 7 |
possible explanation | 7 |
cr programs | 7 |
assessed using | 7 |
occupational therapy | 7 |
qualitative study | 7 |
cerebrovascular diseases | 7 |
social contacts | 7 |
low bias | 7 |
protective effects | 7 |
patient characteristics | 7 |
normotensive patients | 7 |
multicenter study | 7 |
rank test | 7 |
signaling pathways | 7 |
magnetic actuation | 7 |
possible role | 7 |
almost half | 7 |
brain natriuretic | 7 |
skin biopsies | 7 |
successive pregnancy | 7 |
olfactory sensory | 7 |
observed among | 7 |
data reported | 7 |
total number | 7 |
healthcare systems | 7 |
exposure history | 7 |
medical conditions | 7 |
working group | 7 |
single center | 7 |
epidemiological impact | 7 |
national health | 7 |
membrane fusion | 7 |
therapeutic potential | 7 |
risk patients | 7 |
oncologic diseases | 7 |
glycemic control | 7 |
flow index | 7 |
functional impairment | 7 |
hospital mortality | 7 |
previously observed | 7 |
second half | 7 |
demographic data | 7 |
stool donor | 7 |
independent predictors | 7 |
patients compared | 7 |
ethnic disparities | 7 |
sars epidemic | 7 |
transplant patients | 7 |
pcr testing | 7 |
zoonotic spillover | 7 |
organ transplantation | 7 |
bias due | 7 |
calculated using | 7 |
taste perception | 7 |
hypothetical model | 7 |
study covid | 7 |
nurse specialists | 7 |
serum il | 7 |
corrected qt | 7 |
pcr assay | 7 |
metabolic diseases | 7 |
reporting rate | 7 |
patients younger | 7 |
icu care | 7 |
care facility | 7 |
limited number | 7 |
data showed | 7 |
control unit | 7 |
multivariate logistic | 7 |
large population | 7 |
commonly used | 7 |
current evidence | 7 |
endothelial damage | 7 |
mimicry phenomena | 7 |
patients suffering | 7 |
emergency physicians | 7 |
requiring limc | 7 |
significant predictors | 7 |
significantly different | 7 |
coronavirus sars | 7 |
cases diagnosed | 7 |
stress scale | 7 |
severity score | 7 |
direct immunofluorescence | 7 |
peripheral blood | 7 |
fecal material | 7 |
olfactory neurons | 7 |
potential role | 7 |
control study | 7 |
radial peripapillary | 7 |
potential confounders | 7 |
asymptomatic patients | 7 |
critical role | 7 |
pulmonary fibrosis | 7 |
disease outbreak | 7 |
oxygen supplementation | 7 |
cause death | 7 |
average age | 7 |
interim guidance | 7 |
poor health | 7 |
respiratory specimens | 7 |
positive cells | 7 |
medical resources | 7 |
mild covid | 7 |
severe asthma | 7 |
table reports | 7 |
occupational exposure | 7 |
training set | 7 |
pulmonary embolism | 7 |
study date | 7 |
peak vo | 7 |
one hundred | 7 |
inflammatory cytokine | 7 |
pulmonary vascular | 7 |
worse prognosis | 7 |
contact tracing | 7 |
emergency medicine | 7 |
employment outcome | 7 |
heart association | 7 |
based rehabilitation | 7 |
immune responses | 7 |
high mortality | 7 |
myocardial ischemia | 7 |
key role | 7 |
respiratory infections | 7 |
confirmed sars | 7 |
practice guidelines | 7 |
preventive cardiology | 7 |
movement restrictions | 7 |
may represent | 7 |
among women | 7 |
hsp chaperones | 7 |
adaptive immune | 7 |
four patients | 7 |
patients included | 7 |
cutaneous lesions | 7 |
diagnostic tool | 7 |
data set | 7 |
endoscopic capsule | 7 |
rsv infection | 7 |
moderate cases | 7 |
overt dic | 7 |
isncsci motor | 7 |
sufficiently informed | 7 |
study found | 7 |
group showed | 7 |
human ace | 7 |
side effects | 7 |
complication alone | 7 |
greater risk | 7 |
specific antibodies | 7 |
updrs iii | 7 |
ki positive | 7 |
class ii | 7 |
related injuries | 7 |
randomized clinical | 7 |
organ involvement | 7 |
alveolar epithelial | 7 |
randomized trial | 7 |
psychological support | 7 |
deceased patients | 7 |
primary case | 7 |
prospective studies | 7 |
significant positive | 7 |
troponin i | 7 |
patients whose | 7 |
observed characteristics | 7 |
burnout syndrome | 7 |
bouncing spring | 7 |
coronavirus associated | 7 |
control measures | 7 |
sectional survey | 7 |
patients using | 7 |
phylogenetic analysis | 7 |
increased mortality | 7 |
classification i | 7 |
drug discovery | 7 |
motor threshold | 7 |
infections among | 7 |
based robotic | 7 |
clinical study | 7 |
traumatic stress | 7 |
potential therapeutic | 7 |
ritonavir treatment | 7 |
using spss | 7 |
exercise programs | 7 |
hong kong | 7 |
complications due | 7 |
deceased cases | 7 |
serum creatinine | 7 |
current knowledge | 7 |
fatal cases | 7 |
excised porcine | 7 |
one week | 7 |
invasive ventilation | 7 |
similar results | 7 |
sirt activation | 7 |
higher level | 7 |
set consisted | 7 |
yet available | 7 |
muscle strength | 7 |
total score | 7 |
orthodontic treatment | 7 |
life support | 7 |
interstitial pneumonia | 7 |
time window | 7 |
american college | 7 |
lactate dehydrogenase | 7 |
antiviral drugs | 7 |
glucose levels | 7 |
time employment | 6 |
insulin sensitivity | 6 |
via ace | 6 |
asymptomatic carriers | 6 |
small numbers | 6 |
growing number | 6 |
reduced probability | 6 |
given available | 6 |
positive rt | 6 |
deep learning | 6 |
obese mice | 6 |
viral replication | 6 |
ncov infection | 6 |
currently available | 6 |
elevated troponin | 6 |
frequently used | 6 |
dpp i | 6 |
italian normative | 6 |
sequence alignment | 6 |
disorder society | 6 |
essential workers | 6 |
viral entry | 6 |
human body | 6 |
inpatient treatment | 6 |
dermal vessels | 6 |
significantly reduced | 6 |
health commission | 6 |
antiplatelet therapy | 6 |
spectrum endoscopy | 6 |
current restrictions | 6 |
lower rates | 6 |
may occur | 6 |
nursing professionals | 6 |
five percent | 6 |
required intensive | 6 |
sex life | 6 |
age groups | 6 |
cell activation | 6 |
ischemia reperfusion | 6 |
rf model | 6 |
positively associated | 6 |
coronavirus nl | 6 |
viral spike | 6 |
inflammatory drugs | 6 |
quality assessment | 6 |
first follow | 6 |
health interventions | 6 |
cavity formed | 6 |
histopathological characteristics | 6 |
mitochondrial biogenesis | 6 |
state anxiety | 6 |
lipid mediators | 6 |
per year | 6 |
pulmonary infiltrates | 6 |
cardiovascular disorders | 6 |
cognitive impairment | 6 |
time reverse | 6 |
natural history | 6 |
situation reports | 6 |
likert scale | 6 |
mobile balloon | 6 |
require mechanical | 6 |
binding affinity | 6 |
two consecutive | 6 |
inflammatory effects | 6 |
common bile | 6 |
data suggest | 6 |
allergic rhinitis | 6 |
based exercise | 6 |
olfactory bulb | 6 |
without cvd | 6 |
dry cough | 6 |
acute coronary | 6 |
protective equipment | 6 |
stim participants | 6 |
male patients | 6 |
behavioral skills | 6 |
liver enzymes | 6 |
receptor recognition | 6 |
inflammatory disease | 6 |
significant reduction | 6 |
without copd | 6 |
rhinovirus infection | 6 |
blood tests | 6 |
younger patients | 6 |
prior history | 6 |
baseline ecg | 6 |
serological testing | 6 |
treadmill exercise | 6 |
elisa assay | 6 |
cardiac arrest | 6 |
also possible | 6 |
clinical research | 6 |
significant improvements | 6 |
nursing homes | 6 |
dependent enhancement | 6 |
north italy | 6 |
mm dtt | 6 |
daily number | 6 |
optimal threshold | 6 |
prolonged viral | 6 |
fitting results | 6 |
infected people | 6 |
psychological variables | 6 |
antihypertensive treatment | 6 |
patients received | 6 |
serological assays | 6 |
predominantly male | 6 |
colonic wall | 6 |
rpcp fi | 6 |
time estimation | 6 |
functional receptor | 6 |
poor prognosis | 6 |
institutional review | 6 |
oral mucosa | 6 |
patient level | 6 |
psychopathological symptoms | 6 |
controlled study | 6 |
required mechanical | 6 |
substantial human | 6 |
crucial role | 6 |
acid substitutions | 6 |
great interest | 6 |
pathophysiological mechanisms | 6 |
infection may | 6 |
remote patient | 6 |
rheumatoid arthritis | 6 |
common cold | 6 |
flexible colonoscopes | 6 |
san diego | 6 |
positive igg | 6 |
may help | 6 |
bat coronaviruses | 6 |
inflammatory state | 6 |
administrative departments | 6 |
regression models | 6 |
diagnostic workup | 6 |
severe patients | 6 |
ce mark | 6 |
acei group | 6 |
pdb id | 6 |
stress disorder | 6 |
viral loads | 6 |
different viral | 6 |
mainland china | 6 |
mean incubation | 6 |
clinical information | 6 |
scooter accidents | 6 |
epidural stimulation | 6 |
age adjusted | 6 |
high blood | 6 |
series differences | 6 |
thromboembolic complications | 6 |
psychological responses | 6 |
unexplained rpl | 6 |
early transmission | 6 |
position statement | 6 |
better understand | 6 |
cytokine production | 6 |
ptsd symptomatology | 6 |
scale ranging | 6 |
viral genome | 6 |
robotic flexible | 6 |
basic experiments | 6 |
genome sequences | 6 |
rnfl average | 6 |
maximum likelihood | 6 |
gi tract | 6 |
viable virus | 6 |
association among | 6 |
viral clearance | 6 |
sensory neurons | 6 |
stranded rna | 6 |
known pathogens | 6 |
tract infections | 6 |
critical illness | 6 |
php patients | 6 |
territorial areas | 6 |
alveolar epithelium | 6 |
parkinson disease | 6 |
severity scores | 6 |
model performance | 6 |
meier survival | 6 |
less frequently | 6 |
associated factors | 6 |
mean values | 6 |
time interval | 6 |
composite endpoint | 6 |
adhesion molecules | 6 |
entry screening | 6 |
dental monitoring | 6 |
outbreak characteristics | 6 |
severe complications | 6 |
cohort studies | 6 |
previous pregnancy | 6 |
sexual health | 6 |
using vr | 6 |
pandemic outbreak | 6 |
least days | 6 |
somatic symptoms | 6 |
peripapillary capillary | 6 |
epidural spinal | 6 |
ts mis | 6 |
training alone | 6 |
pulmonary function | 6 |
secondary infection | 6 |
parathyroid histotypes | 6 |
became afebrile | 6 |
qualitative research | 6 |
bat origin | 6 |
highly conserved | 6 |
reperfusion injury | 6 |
structural proteins | 6 |
gender differences | 6 |
may affect | 6 |
aldosterone level | 6 |
significantly improve | 6 |
vocational rehabilitation | 6 |
full model | 6 |
health benefits | 6 |
health emergency | 6 |
preconception health | 6 |
multidisciplinary cr | 6 |
mean difference | 6 |
high sensitivity | 6 |
zoonotic transmission | 6 |
standard deviations | 6 |
distance walked | 6 |
model systems | 6 |
intervention strategy | 6 |
shown promise | 6 |
coping strategy | 6 |
employment probability | 6 |
pathological conditions | 6 |
human cd | 6 |
central nervous | 6 |
study using | 6 |
initial spo | 6 |
pregnancy complication | 6 |
liver disease | 6 |
coagulation disorders | 6 |
cardiac fibrosis | 6 |
plasminogen activator | 6 |
term progression | 6 |
roc curve | 6 |
near future | 6 |
case definition | 6 |
among police | 6 |
two major | 6 |
lung function | 6 |
absolute lymphocyte | 6 |
current sars | 6 |
stable psychological | 6 |
symptom onset | 6 |
burnout among | 6 |
antihypertensive drugs | 6 |
significant predictor | 6 |
short time | 6 |
everyday life | 6 |
scoring system | 6 |
critical appraisal | 6 |
temporal changes | 6 |
pharma gmbh | 6 |
status one | 6 |
hcl ph | 6 |
moderate course | 6 |
descriptive study | 6 |
blood donors | 6 |
reverse transcription | 6 |
kidney disorder | 6 |
qtc ms | 6 |
dependent rna | 6 |
therapeutic targets | 6 |
higher scores | 6 |
policy statement | 6 |
muscle activation | 6 |
study performed | 6 |
ed nurses | 6 |
coagulation cascade | 6 |
input variables | 6 |
spss software | 6 |
risks associated | 6 |
therapeutic procedures | 6 |
early predictors | 6 |
supplementary item | 6 |
randomised controlled | 6 |
coronavirus pandemic | 6 |
qt prolongation | 6 |
untraced cases | 6 |
iga antibodies | 6 |
sirt may | 6 |
years vs | 6 |
duct stones | 6 |
primary rpl | 6 |
monoclonal antibody | 6 |
acute cholangitis | 6 |
replacement therapy | 6 |
choroidal thickness | 6 |
center study | 6 |
pd nurse | 6 |
mild course | 6 |
cancer cells | 6 |
electric actuation | 6 |
average number | 6 |
ejection fraction | 6 |
ct value | 6 |
recurrent miscarriage | 6 |
supplementary material | 6 |
pulse oximetry | 6 |
employment outcomes | 6 |
scientific evidence | 6 |
included patients | 6 |
binding protein | 6 |
asymptomatic cases | 6 |
may cause | 6 |
later phase | 6 |
therapeutic effects | 6 |
comprehensive review | 6 |
negative scintigraphy | 6 |
plastic stents | 6 |
two studies | 6 |
novel therapies | 6 |
infarct size | 6 |
medical device | 6 |
disease among | 6 |
mm nacl | 6 |
mm tris | 6 |
infection via | 5 |
two days | 5 |
study provides | 5 |
target cells | 5 |
initial rr | 5 |
coronavirus spike | 5 |
min walk | 5 |
animal model | 5 |
control studies | 5 |
normal healthy | 5 |
blood count | 5 |
associated skin | 5 |
induced ards | 5 |
compassion fatigue | 5 |
random forest | 5 |
adults aged | 5 |
radiological findings | 5 |
important lessons | 5 |
many cases | 5 |
multiorgan failure | 5 |
coagulation parameters | 5 |
independence measure | 5 |
clinical manifestation | 5 |
initial symptoms | 5 |
care services | 5 |
less variable | 5 |
increased prevalence | 5 |
exosomes derived | 5 |
patients often | 5 |
recently published | 5 |
thrombus formation | 5 |
per se | 5 |
marrow mscs | 5 |
stand manoeuvre | 5 |
ace host | 5 |
outcome data | 5 |
limb motor | 5 |
neoguide endoscopy | 5 |
hand hygiene | 5 |
often require | 5 |
like symptoms | 5 |
incomplete kd | 5 |
electric scooters | 5 |
patient data | 5 |
breast cancer | 5 |
may induce | 5 |
alveolar fluid | 5 |
patient population | 5 |
mean time | 5 |
disease pathogenesis | 5 |
sore throat | 5 |
cardiac manifestations | 5 |
gastrointestinal endoscopy | 5 |
data protection | 5 |
higher score | 5 |
reverse transcriptase | 5 |
ncov outbreak | 5 |
rural areas | 5 |
resveratrol inhibits | 5 |
skills model | 5 |
mitochondrial diseases | 5 |
living cases | 5 |
quarantine period | 5 |
overall population | 5 |
middle cerebral | 5 |
motor recovery | 5 |
eosinophilic airway | 5 |
effective intervention | 5 |
chest pain | 5 |
uc patients | 5 |
endoscopic biliary | 5 |
macrophage inflammatory | 5 |
fold cross | 5 |
infect humans | 5 |
bat coronavirus | 5 |
signaling pathway | 5 |
severe pneumonia | 5 |
higher among | 5 |
adverse clinical | 5 |
two main | 5 |
cases outside | 5 |
markedly elevated | 5 |
plasma levels | 5 |
roc curves | 5 |
intravascular coagulopathy | 5 |
preliminary results | 5 |
significance level | 5 |
related themes | 5 |
ethical committee | 5 |
previously published | 5 |
positive igm | 5 |
strongly recommended | 5 |
also demonstrated | 5 |
literature search | 5 |
patients dying | 5 |
travel restrictions | 5 |
safe sexual | 5 |
increasing number | 5 |
south italy | 5 |
high number | 5 |
patients receiving | 5 |
heart transplant | 5 |
will allow | 5 |
emergency nurses | 5 |
secondary transmission | 5 |
women reported | 5 |
one month | 5 |
without cad | 5 |
eligible patients | 5 |
liver disorders | 5 |
common exposure | 5 |
emergency use | 5 |
partial pressure | 5 |
ucb pharma | 5 |
early identification | 5 |
lower level | 5 |
nasal epithelial | 5 |
viral transmission | 5 |
quality control | 5 |
acute exacerbations | 5 |
iii scores | 5 |
parathyroid tumors | 5 |
residue range | 5 |
longer los | 5 |
five patients | 5 |
fisher exact | 5 |
burnout en | 5 |
related pancreatitis | 5 |
experiments using | 5 |
kg min | 5 |
motor function | 5 |
treatment groups | 5 |
insertion tube | 5 |
new perspectives | 5 |
factors influencing | 5 |
novel therapeutic | 5 |
median duration | 5 |
plasma cells | 5 |
airway epithelium | 5 |
flow chart | 5 |
simple statistical | 5 |
axis represents | 5 |
irritable bowel | 5 |
mainly due | 5 |
therapeutic strategies | 5 |
lung involvement | 5 |
office appointments | 5 |
sick leave | 5 |
counterfactual scenario | 5 |
future perspectives | 5 |
angiotensin i | 5 |
small molecule | 5 |
ps matching | 5 |
worse outcomes | 5 |
published studies | 5 |
zoonotic origin | 5 |
student status | 5 |
information available | 5 |
autopsy findings | 5 |
cumulative total | 5 |
study investigated | 5 |
hospital death | 5 |
icu beds | 5 |
average speed | 5 |
care provider | 5 |
among people | 5 |
will require | 5 |
tai chi | 5 |
olfactory dysfunction | 5 |
including wuhan | 5 |
cardiovascular complications | 5 |
rpcp pd | 5 |
early outbreak | 5 |
human mesenchymal | 5 |
stone extraction | 5 |
recent evidence | 5 |
reduced social | 5 |
public discussion | 5 |
orthodontic emergencies | 5 |
healthy individuals | 5 |
severe infections | 5 |
approximately days | 5 |
online survey | 5 |
inflammatory factors | 5 |
operating characteristic | 5 |
potential drug | 5 |
healthy change | 5 |
entry receptor | 5 |
electric scooter | 5 |
group vs | 5 |
akt pathway | 5 |
bowel syndrome | 5 |
metabolic disorders | 5 |
prospective study | 5 |
living treatment | 5 |
psychological well | 5 |
success rate | 5 |
employed individuals | 5 |
obese participants | 5 |
cell responses | 5 |
igg indexes | 5 |
among different | 5 |
mitochondrial respiratory | 5 |
single primary | 5 |
cord mesenchymal | 5 |
healthy weight | 5 |
molecular testing | 5 |
using publicly | 5 |
best possible | 5 |
complete blood | 5 |
network care | 5 |
supplemental oxygen | 5 |
iga results | 5 |
rehabilitation section | 5 |
better health | 5 |
patients older | 5 |
cumulative incidence | 5 |
relatively high | 5 |
low level | 5 |
inflammatory conditions | 5 |
women expressed | 5 |
inhibits il | 5 |
wuhan municipal | 5 |
negative correlation | 5 |
volitional muscle | 5 |
distal tip | 5 |
membrane oxygenation | 5 |
cases generated | 5 |
police officers | 5 |
substantial proportion | 5 |
false positives | 5 |
much lower | 5 |
systemic inflammatory | 5 |
perfusion density | 5 |
independent variables | 5 |
research group | 5 |
average score | 5 |
flow nasal | 5 |
time rt | 5 |
current literature | 5 |
seven patients | 5 |
positive subjects | 5 |
study cohort | 5 |
personal data | 5 |
nationwide study | 5 |
significantly increased | 5 |
social functioning | 5 |
repeated measures | 5 |
spike proteins | 5 |
like protease | 5 |
axial myopia | 5 |
clinical presentation | 5 |
monocyte chemoattractant | 5 |
advanced life | 5 |
cell infection | 5 |
rpcp flow | 5 |
neonatal health | 5 |
core data | 5 |
active reporting | 5 |
food decisions | 5 |
chemoattractant protein | 5 |
clinical evidence | 5 |
significant proportion | 5 |
cases reported | 5 |
existing cvd | 5 |
electronic medical | 5 |
labor market | 5 |
participants also | 5 |
pneumatic actuation | 5 |
eight patients | 5 |
subsequent pregnancy | 5 |
pathological findings | 5 |
three groups | 5 |
municipal health | 5 |
high school | 5 |
bronchial epithelial | 5 |
potential donors | 5 |
ncov cases | 5 |
years worked | 5 |
significant correlation | 5 |
psychological adjustment | 5 |
homotrimer spike | 5 |
influenza viruses | 5 |
als team | 5 |
one child | 5 |
total cohort | 5 |
moderate clinical | 5 |
smoking cessation | 5 |
childbearing age | 5 |
table presents | 5 |
sars outbreak | 5 |
findings may | 5 |
flow oxygen | 5 |
north america | 5 |
index case | 5 |
pulmonary edema | 5 |
study aimed | 5 |
overall period | 5 |
asthma mouse | 5 |
coping style | 5 |
early detection | 5 |
extracorporeal membrane | 5 |
feature vector | 5 |
death rate | 5 |
nasopharyngeal swabs | 5 |
health behaviours | 5 |
endoscopic retrograde | 5 |
epidural scs | 5 |
metallic stent | 5 |
permanent magnets | 5 |
allowed us | 5 |
related accidents | 5 |
cd domains | 5 |
including ischemic | 5 |
score matching | 5 |
using data | 5 |
study group | 5 |
conducted using | 5 |
predisposing factors | 5 |
live birth | 5 |
larger trial | 5 |
lower airways | 5 |
heart tissue | 5 |
internal consistency | 5 |
fold increase | 5 |
hospital stay | 5 |
hemostatic biomarkers | 5 |
nyha classification | 5 |
abdominal pain | 5 |
cardiovascular mortality | 5 |
alveolar edema | 5 |
also considered | 5 |
major adverse | 5 |
higher incidence | 5 |
limited data | 5 |
also showed | 5 |
wireless capsule | 5 |
preliminary report | 5 |
electric motor | 5 |
systemic symptoms | 5 |
novel virus | 5 |
multivariable regression | 5 |
enrolled patients | 5 |
employment one | 5 |
general italian | 5 |
related liver | 5 |
retained biliary | 5 |
left coronary | 5 |
taste buds | 5 |
treatment planning | 5 |
novel corona | 5 |
like locomotion | 5 |
coagulation system | 5 |
infection prevention | 5 |
almost within | 5 |
transcription polymerase | 5 |
also observed | 5 |
six patients | 5 |
fat diet | 5 |
activation depression | 5 |
immune dysfunction | 5 |
lupus erythematosus | 5 |
current covid | 5 |
complete injuries | 5 |
way repeated | 5 |
cytopathic effect | 5 |
reporting means | 5 |
ts patients | 5 |
positive effect | 5 |
elisa assays | 5 |
measures anova | 5 |
obesity prevention | 5 |
blood vessels | 5 |
received honoraria | 5 |
soft material | 5 |
adaptive immunity | 5 |
emg data | 5 |
outcome measure | 5 |
mtdna mutations | 5 |
times higher | 5 |
rat model | 5 |
inflammatory protein | 5 |
much information | 5 |
pao fio | 5 |
insulin resistance | 5 |
among adults | 5 |
daily physical | 5 |
derived growth | 5 |
among ed | 5 |
job burnout | 5 |
thrombotic complications | 5 |
higher odds | 5 |
results indicate | 5 |
outpatient care | 5 |
growth rate | 5 |
coronavirus hku | 5 |
relative abundance | 5 |
useful tool | 5 |
venous thromboembolism | 5 |
severe symptoms | 5 |
peristaltic motion | 5 |
quantitative variables | 5 |
based interventions | 5 |
vascular endothelium | 5 |
disorder specialist | 5 |
older people | 5 |
health behaviour | 5 |
epidemiological data | 5 |
time course | 5 |
training session | 5 |
may allow | 5 |
stroke patients | 5 |
severe sars | 5 |
olfactory mucosa | 5 |
mixed methods | 5 |
clinically significant | 5 |
therapeutic effect | 5 |
previously known | 5 |
modelling study | 5 |
laboratory findings | 5 |
log rank | 5 |
individual differences | 5 |
weight control | 5 |
positive significant | 5 |
abnormal echocardiograms | 5 |
stimulation intensities | 5 |
jaam dic | 5 |
ace angiotensin | 5 |
life events | 5 |
structural studies | 5 |
significantly reduce | 5 |
large proportion | 5 |
one possible | 5 |
increased expression | 5 |
among aas | 5 |
symptomatic covid | 5 |
nasal cannula | 5 |
emerging infectious | 5 |
still limited | 5 |
plasma renin | 5 |
rpcp perfusion | 5 |
american heart | 5 |
inflammation will | 5 |
mitochondrial membrane | 5 |
significant association | 5 |
primary hyperparathyroidism | 5 |
severe tbi | 5 |
personal protective | 5 |
microbiota composition | 5 |
disease outbreaks | 5 |
surveillance data | 5 |
based study | 5 |
drug use | 5 |
incomplete sci | 5 |
descriptive analysis | 5 |
distance without | 5 |
endoscopy system | 5 |
blood platelets | 5 |
score positively | 5 |
female patients | 5 |
study measurements | 5 |
reproduction numbers | 5 |
minute walk | 5 |
ace inhibitors | 5 |
new information | 5 |
immune complex | 4 |
vulnerable populations | 4 |
isth overt | 4 |
infection compared | 4 |
using nasopharyngeal | 4 |
tobacco use | 4 |
hard endpoint | 4 |
mount sinai | 4 |
death worldwide | 4 |
current state | 4 |
estimated epidemic | 4 |
abruptio placentae | 4 |
high percentage | 4 |
co score | 4 |
image analysis | 4 |
overall study | 4 |
lesions related | 4 |
orthodontic patients | 4 |
estimated values | 4 |
viral culture | 4 |
highest specificity | 4 |
resistance system | 4 |
transforming growth | 4 |
marrow mesenchymal | 4 |
likelihood method | 4 |
dental care | 4 |
colorectal polyps | 4 |
granulocyte colony | 4 |
dispositional traits | 4 |
fatal outcomes | 4 |
care providers | 4 |
made available | 4 |
healthcare personnel | 4 |
predictive factors | 4 |
diagnostic tests | 4 |
survivor group | 4 |
provide additional | 4 |
feature selection | 4 |
post training | 4 |
distance metrics | 4 |
educational level | 4 |
life outcomes | 4 |
health services | 4 |
immunodeficiency virus | 4 |
probable bat | 4 |
cov spike | 4 |
ideal donor | 4 |
will continue | 4 |
brain cells | 4 |
also present | 4 |
excluding wuhan | 4 |
complete lockdown | 4 |
median days | 4 |
dichotomous questions | 4 |
ileocecal valve | 4 |
damage caused | 4 |
term results | 4 |
squared test | 4 |
immersive virtual | 4 |
healthy controls | 4 |
recently proposed | 4 |
live births | 4 |
balance board | 4 |
side lus | 4 |
lumbar spinal | 4 |
neurological manifestations | 4 |
study carried | 4 |
major risk | 4 |
highly permissive | 4 |
dynamic risk | 4 |
evaluated using | 4 |
patients required | 4 |
opening remarks | 4 |
posttraumatic stress | 4 |
mesenchymal stromal | 4 |
respiratory form | 4 |
measured using | 4 |
first identified | 4 |
preferred reporting | 4 |
third follow | 4 |
proposed approach | 4 |
via telephone | 4 |
retained stents | 4 |
multilevel mixed | 4 |
nine participants | 4 |
allergic airway | 4 |
randomly selected | 4 |
invendoscopy tm | 4 |
sham intervention | 4 |
road traffic | 4 |
epidemiological analysis | 4 |
among health | 4 |
grover disease | 4 |
received ivig | 4 |
colon examination | 4 |
pack year | 4 |
adjusted odds | 4 |
autoimmune diseases | 4 |
making healthy | 4 |
monocyte infiltration | 4 |
traditional colonoscopy | 4 |
fetal anomalies | 4 |
point scale | 4 |
rna genome | 4 |
last decade | 4 |
increased surface | 4 |
local thrombus | 4 |
copd population | 4 |
may provide | 4 |
respiratory function | 4 |
sirt levels | 4 |
oxygen support | 4 |
positive association | 4 |
risk score | 4 |
slightly higher | 4 |
based virtual | 4 |
th percentiles | 4 |
neutrophilic inflammation | 4 |
studies registered | 4 |
sex workers | 4 |
sleeve mechanism | 4 |
thematic analysis | 4 |
comparing baseline | 4 |
targeting sirt | 4 |
renal replacement | 4 |
infection control | 4 |
meier method | 4 |
adverse remodeling | 4 |
medical robots | 4 |
classical kd | 4 |
elisa igg | 4 |
neuronal death | 4 |
clinical presentations | 4 |
study included | 4 |
exponential growing | 4 |
type receptor | 4 |
peak bnp | 4 |
nasal epithelia | 4 |
ct scans | 4 |
direct contact | 4 |
drug interactions | 4 |
mean square | 4 |
four weeks | 4 |
surgical treatment | 4 |
term safety | 4 |
pp ab | 4 |
highest sensitivity | 4 |
cardiac cells | 4 |
treatment option | 4 |
since december | 4 |
another limitation | 4 |
within normal | 4 |
group participants | 4 |
presenting characteristics | 4 |
mild tbi | 4 |
new technologies | 4 |
elicit lower | 4 |
anxiety disorders | 4 |
upper airway | 4 |
take place | 4 |
might affect | 4 |
transcription factors | 4 |
rapid palatal | 4 |
tissue samples | 4 |
alveolar cells | 4 |
composite parameters | 4 |
protein serves | 4 |
scientific literature | 4 |
time spent | 4 |
protocol number | 4 |
distinctive features | 4 |
psychological consequences | 4 |
abbvie gmbh | 4 |
cases per | 4 |
soft robot | 4 |
underserved communities | 4 |
virus causing | 4 |
painless colonoscopy | 4 |
risk assessment | 4 |
syndrome associated | 4 |
sessions per | 4 |
structural oct | 4 |
long structural | 4 |
antibody titer | 4 |
bonferroni correction | 4 |
definitive endoscopic | 4 |
wilk test | 4 |
progressive viral | 4 |
study also | 4 |
international spread | 4 |
selected based | 4 |
screening tool | 4 |
energy expenditure | 4 |
exercise testing | 4 |
positive patients | 4 |
pathogenic mechanism | 4 |
pathological processes | 4 |
compared using | 4 |
lung tissue | 4 |
five participants | 4 |
daily living | 4 |
rna detection | 4 |
threshold scs | 4 |
taken together | 4 |
studies performed | 4 |
intervention components | 4 |
chest radiographs | 4 |
performed according | 4 |
amino acids | 4 |
infected cells | 4 |
mostly due | 4 |
profile likelihood | 4 |
intensity medical | 4 |
glasgow outcome | 4 |
gbvi wsa | 4 |
overall mortality | 4 |
root mean | 4 |
degradation products | 4 |
scope system | 4 |
activator inhibitor | 4 |
physical contact | 4 |
provide information | 4 |
provide useful | 4 |
digital technology | 4 |
ev administration | 4 |
progressively throughout | 4 |
first study | 4 |
histological evidence | 4 |
analysis investigating | 4 |
parenchymal abnormalities | 4 |
prehospital paris | 4 |
mainly associated | 4 |
using salivary | 4 |
arf treatment | 4 |
wholesale market | 4 |
cytokine profiles | 4 |
observational cohort | 4 |
attitudes toward | 4 |
loop formation | 4 |
cardiopulmonary exercise | 4 |
healthy control | 4 |
different timepoints | 4 |
ai systems | 4 |
compliance rate | 4 |
among sestamibi | 4 |
several hemostatic | 4 |
supply network | 4 |
hospitalized cases | 4 |
high quality | 4 |
multiple imputation | 4 |
center experience | 4 |
respiratory society | 4 |
severe illness | 4 |
dipeptidyl peptidase | 4 |
lines represent | 4 |
hip knee | 4 |
month period | 4 |
impaired cognition | 4 |
may require | 4 |
data obtained | 4 |
high speed | 4 |
open reading | 4 |
acute exacerbation | 4 |
mortality risk | 4 |
approximately one | 4 |
incomplete injuries | 4 |
one third | 4 |
pregnancy losses | 4 |
health workers | 4 |
lysosomal storage | 4 |
disease burden | 4 |
nationwide analysis | 4 |
lung inflammation | 4 |
transplant patient | 4 |
conventional therapeutic | 4 |
innate immune | 4 |
poor gas | 4 |
trauma centers | 4 |
model constructs | 4 |
interpersonal challenges | 4 |
observing disease | 4 |
capacity throughout | 4 |
lymphocyte counts | 4 |
essential epidemic | 4 |
seafood wholesale | 4 |
healthy women | 4 |
refractory asthma | 4 |
igg results | 4 |
recent systematic | 4 |
observed cases | 4 |
problem solving | 4 |
research team | 4 |
high rates | 4 |
targeted therapy | 4 |
polyp detection | 4 |
multivariate analyses | 4 |
present analysis | 4 |
analysis based | 4 |
metallic stents | 4 |
human bronchial | 4 |
observed data | 4 |
inference using | 4 |
police units | 4 |
among severe | 4 |
protein kinase | 4 |
growth restriction | 4 |
mononuclear cells | 4 |
enzyme protects | 4 |
hygienic measures | 4 |
interventions may | 4 |
higher rate | 4 |
progression patterns | 4 |
delayed recovery | 4 |
also associated | 4 |
italian government | 4 |
processed using | 4 |
information technology | 4 |
took place | 4 |
high proportion | 4 |
coronary syndrome | 4 |
second step | 4 |
spontaneous miscarriage | 4 |
effects regression | 4 |
healthy eating | 4 |
knee joint | 4 |
idiopathic pulmonary | 4 |
life cycle | 4 |
epidemic spread | 4 |
evolutionary analysis | 4 |
reproductive health | 4 |
protein gene | 4 |
type iii | 4 |
several factors | 4 |
based medicine | 4 |
innate lymphoid | 4 |
recipients covid | 4 |
home therapy | 4 |
external locus | 4 |
health behaviors | 4 |
levels among | 4 |
human immunodeficiency | 4 |
normally distributed | 4 |
bivariate analysis | 4 |
pcr result | 4 |
high degree | 4 |
pandemic influenza | 4 |
posterior root | 4 |
limb extension | 4 |
admitted patients | 4 |
using machine | 4 |
alveolar dysfunction | 4 |
medical record | 4 |
fda approved | 4 |
post sars | 4 |
elderly comorbid | 4 |
medication adherence | 4 |
remains controversial | 4 |
clinical assessment | 4 |
therapeutic agents | 4 |
functional status | 4 |
swab samples | 4 |
human studies | 4 |
brigade als | 4 |
defined according | 4 |
comorbidities associated | 4 |
personal contact | 4 |
without symptoms | 4 |
disease caused | 4 |
shock syndrome | 4 |
civilian employees | 4 |
like receptor | 4 |
local ethics | 4 |
confounding variables | 4 |
severity groups | 4 |
case data | 4 |
using exported | 4 |
first phase | 4 |
deleterious effects | 4 |
abnormal echocardiogram | 4 |
paediatric multisystem | 4 |
improving cognitive | 4 |
medical personnel | 4 |
induced allergic | 4 |
significantly older | 4 |
positive sars | 4 |
dispersion parameter | 4 |
scim iii | 4 |
equivocal igm | 4 |
highly effective | 4 |
gene expression | 4 |
gestational complications | 4 |
multivariable model | 4 |
low cost | 4 |
healthcare provider | 4 |
health equity | 4 |
depth maps | 4 |
bame background | 4 |
study revealed | 4 |
fit exercise | 4 |
maslach burnout | 4 |
ex juvantibus | 4 |
total population | 4 |
rapidly spread | 4 |
glucose metabolism | 4 |
five days | 4 |
oxygen therapy | 4 |
expression ace | 4 |
flexible options | 4 |
cardiovascular rehabilitation | 4 |
cardiac troponin | 4 |
coronavirus strains | 4 |
heart transplantation | 4 |
multivariable analysis | 4 |
clotting activation | 4 |
resource availability | 4 |
md simulation | 4 |
markedly higher | 4 |
social motivation | 4 |
breast milk | 4 |
fatty acid | 4 |
significantly greater | 4 |
higher chance | 4 |
health questionnaire | 4 |
health conditions | 4 |
stent diameter | 4 |
childhood asthma | 4 |
screening effort | 4 |
creatine kinase | 4 |
management support | 4 |
evidence shows | 4 |
mm imidazole | 4 |
women noted | 4 |
outcomes following | 4 |
cervical insufficiency | 4 |
keratinocyte growth | 4 |
propelling robotic | 4 |
antiphospholipid antibodies | 4 |
symptom resolution | 4 |
greater proportion | 4 |
negative rt | 4 |
also marked | 4 |
imaging features | 4 |
incomplete colonoscopy | 4 |
convalescent plasma | 4 |
clinical indications | 4 |
research groups | 4 |
icu hospitalized | 4 |
integrated care | 4 |
prevention strategies | 4 |
highest prevalence | 4 |
shows examples | 4 |
isocitrate dehydrogenase | 4 |
preventive programs | 4 |
may benefit | 4 |
vision tm | 4 |
treatment outcomes | 4 |
different types | 4 |
center cohort | 4 |
voluntary motor | 4 |
oxygen partial | 4 |
best fit | 4 |
variable stiffness | 4 |
care options | 4 |
pulmonary arterial | 4 |
abnormal coagulation | 4 |
protein using | 4 |
becomes available | 4 |
ki expression | 4 |
arm loading | 4 |
following parameters | 4 |
reporting items | 4 |
growth factors | 4 |
health literacy | 4 |
mammalian target | 4 |
studies indicating | 4 |
women conceded | 4 |
required prehospital | 4 |
survival curves | 4 |
also suggested | 4 |
respiratory mucosa | 4 |
post tbi | 4 |
relatively long | 4 |
months vs | 4 |
taste papillae | 4 |
linear correlation | 4 |
fatality risk | 4 |
statistical package | 4 |
higher viral | 4 |
national census | 4 |
putative recombination | 4 |
imputed data | 4 |
weight support | 4 |
example item | 4 |
upper limb | 4 |
sleep disturbance | 4 |
american thoracic | 4 |
nursing home | 4 |
horizontal axis | 4 |
although patients | 4 |
avian influenza | 4 |
outbreak associated | 4 |
whole study | 4 |
liver injury | 4 |
often used | 4 |
patients presenting | 4 |
without prehospital | 4 |
percentage value | 4 |
specific igm | 4 |
imbalance problem | 4 |
fda mark | 4 |
spread worldwide | 4 |
patients suffered | 4 |
current research | 4 |
census data | 4 |
causal relationship | 4 |
toxic shock | 4 |
currently unknown | 4 |
fibrin degradation | 4 |
including sars | 4 |
weight gain | 4 |